4-[(5-Chloropyridin-2-yl)oxy]aniline

Catalog No.: 
ACRZHQ956
CAS No.: 
73474-62-1
Molecular Formula: 
C11H9ClN2O
Molecular Weight: 
220.66
4-[(5-Chloropyridin-2-yl)oxy]aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$86.00InquiryInquiry
100mg95%$124.00InquiryInquiry
250mg95%$168.00InquiryInquiry
1g95%$421.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(5-Chloropyridin-2-yl)oxy]aniline
IUPAC Name4-((5-chloropyridin-2-yl)oxy)aniline
MDL No.MFCD06825488
Molecular FormulaC11H9ClN2O
Molecular Weight220.66
SMILESNC1=CC=C(OC2=NC=C(Cl)C=C2)C=C1
InChI KeyQBVYTFQMWSDIJO-UHFFFAOYSA-N
Synonym4-[(5-chloropyridin-2-yl)oxy]aniline;Benzenamine, 4-[(5-chloro-2-pyridinyl)oxy]-;4-[(5-Chloro-2-pyridinyl)oxy]benzenamine
CAS No.73474-62-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRZHQ956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNYFL503 route compound structure diagram
    ACNYFL50316110-09-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZHQ956 route product structure diagram
    ACRZHQ95673474-62-1
Inquiry

2. ACRZHQ956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRZHQ956 route product structure diagram
    ACRZHQ95673474-62-1
Inquiry

3. ACRZHQ956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZHQ956 route product structure diagram
    ACRZHQ95673474-62-1
Inquiry

Comments (0)